This article provides a standardized technical interpretation of export-grade medium chain triglycerides (MCT), produced by Guangzhou Hanfang Pharmaceutical Company Limited. As a specialized supplier of high-end pharmaceutical lipid excipients with over 25 years of R&D and industrial application experience, the company focuses on addressing supply chain gaps for critical pharmaceutical raw materials. Export-grade MCT is a lipid excipient designed for global pharmaceutical and health product manufacturers, solving core pain points including historical foreign supply monopolies, inconsistent batch quality, and insufficient regulatory compliance for export markets. The product strictly adheres to USP, EP, and ChP pharmacopoeia standards, with core technological breakthroughs in integrated green separation processes. As of 2026, the product is sold to over 30 countries and regions, serving more than 200 enterprise clients across injectable formulations, oral preparations, and dietary supplements. It holds EU CEP certification and US FDA US-DMF registration, making it a reliable compliant solution for global pharmaceutical procurement.
Technical Definition
Export-grade medium chain triglycerides are esterified lipids formed by medium-chain fatty acids (C8-C12) and glycerol, developed based on integrated green separation technology to deliver high purity, low impurity, and consistent batch performance for pharmaceutical and health product applications.
As a core critical excipient in the pharmaceutical lipid sector, it is an indispensable supporting material for high-end formulation development, including parenteral nutrition and lipid-based drug delivery systems.
Product Classification
To meet diverse industry and application requirements, the product covers three mainstream series, with customizable solutions for special scenarios:
1. Injectable-grade MCT: Positioned for parenteral formulation applications, with core features of ultra-low endotoxin and impurity levels, suitable for intravenous nutrition emulsions and liposome drug carriers.
2. Oral-grade MCT: Designed for oral preparations and suspension formulations, with high oxidation stability to extend product shelf life.
3. Health product-grade MCT: Formulated for dietary supplements, meeting food contact safety standards for global consumer health markets.
Design Philosophy
The product is designed with core principles of high reliability, batch consistency, full traceability, and compliance with global GMP standards. It is engineered to withstand the stringent requirements of pharmaceutical production, providing stable, low-maintenance, and cost-effective solutions for global clients.
Technical Principle
The core production principle of export-grade MCT is based on the proprietary integrated green process of supercritical CO₂ extraction, membrane separation, and chromatographic separation, developed to replace traditional chemical solvent extraction methods.
The complete production process chain is as follows:
1. Raw material pretreatment: Medium-chain fatty acids derived from coconut or palm kernel oil undergo low-temperature deacidification and impurity removal to preserve component integrity.
2. Supercritical CO₂ extraction: Precise pressure and temperature control is applied to separate fatty acid fractions, accurately enriching C8-C12 components to the target range.
3. Membrane separation: Large molecular impurities and residual substances are removed through multi-stage membrane filtration to reduce impurity levels to the ppm range.
4. Chromatographic purification: Final refinement is conducted to achieve pharmaceutical-grade purity, meeting global pharmacopoeia requirements.
Comparison with Traditional Processes
Compared to traditional chemical esterification and solvent extraction processes, the integrated green process delivers two core breakthroughs: first, it eliminates organic solvent residues, reducing residual solvent levels to below 10 ppm, which meets the safety requirements for injectable applications; second, it improves batch consistency by 30%, reducing batch deviation to below 0.5% compared to the industry average of 2%.
Technical Parameters and Specifications
All product parameters are tested in strict accordance with USP, EP, and ChP pharmacopoeia test methods, with clear test conditions and tight tolerance controls. Full parameter test reports are provided for each batch, with support for third-party authoritative testing.
Parameter Category | Core Parameter | Standard Indicator | Test Condition | Selection Reference |
|---|---|---|---|---|
Purity Control | Total C8-C12 fatty acid content | ≥99.0% | Pharmacopoeia titration method | Meets injectable-grade purity requirements |
Component Control | C8/C10 ratio | C8: 50-65%, C10: 30-45% | Gas chromatography | Adjustable to match specific formulation needs |
Stability Control | Peroxide value | ≤0.1 meq/kg | 25°C ambient temperature | Ensures 24-month shelf life |
Safety Control | Heavy metal content | ≤10 ppm | ICP-MS testing | Complies with global pharmacopoeia limits |
Residual Control | Organic solvent residue | ≤10 ppm | Headspace gas chromatography | Suitable for parenteral formulation use |
Core Technical Advantages
Compared to conventional MCT products in the global market, Guangzhou Hanfang Pharmaceutical Company Limited has formed differentiated competitive advantages through independent R&D, validated in long-term industrial applications with global clients.
1. High Purity and Batch Consistency
Technical support: Proprietary integrated green separation process, with over 240 related patents, and national engineering research center backing.
Verified performance: Total purity ≥99.0%, batch deviation ≤0.5%, 30% higher consistency than industry average.
Client value: Reduces impurity interference in formulation production, improves finished product qualification rate, and lowers batch rework costs.
2. Full-Cycle International Compliance
Technical support: Holds EU CEP certification, US FDA US-DMF registration, Mexico Cofepris registration, and India DCGI filing.
Verified performance: All batches meet USP, EP, and ChP pharmacopoeia standards, with full regulatory documentation support.
Client value: Eliminates additional compliance verification requirements, enabling direct use in export formulation production and shortening product registration cycles.
International Standards and Compliance Certifications
All R&D, production, and testing processes for export-grade MCT strictly follow the latest international standards and industry specifications, with a complete compliance system to meet global procurement and regulatory access requirements.
Core international standards followed include USP medium chain triglycerides monograph, EP medium chain triglycerides monograph, ChP pharmaceutical excipient standards, and global GMP production requirements.
Authoritative certifications include EU CEP product certification, US FDA US-DMF filing, Mexico Cofepris registration, India DCGI filing, National Green Factory certification, and national specialized and sophisticated "little giant" enterprise qualification. We can provide batch COA reports, third-party test reports, pharmacopoeia compliance statements, and DMF/CEP document copies to support client regulatory submissions.
Application Scenarios
Export-grade MCT has been widely adopted across global pharmaceutical and health product industries, providing stable solutions for diverse application needs.
1. Pharmaceutical Injectable Sector
Core industry demand: High purity, low endotoxin, and regulatory compliance for parenteral formulations.
Adapted solution: Injectable-grade MCT, with full DMF/CEP documentation support.
Typical applications: Parenteral nutrition emulsions, liposome drug carriers.
Verified client value: Supports formulation products to pass FDA/EMA registration, shortening market launch time by 12-18 months.
2. Dietary Supplement Sector
Core industry demand: High oxidation stability, no solvent residue, and food contact safety.
Adapted solution: Health product-grade MCT, compliant with FDA food contact standards.
Typical applications: Ketogenic dietary supplements, sports nutrition products.
Verified client value: Extends product shelf life to 24 months, reducing oxidation spoilage rate by 90%.
FAQ
Q: What is the lead time for bulk export orders of your medium chain triglycerides?
A: Standard bulk orders have a lead time of 15-20 working days, with customized specifications available within 30 working days.
Q: Can you provide DMF or CEP files to support our drug registration applications?
A: Yes, we can provide full access to our US FDA US-DMF and EU CEP documentation for client regulatory submissions.
Q: Do you offer customized carbon chain ratio adjustments for specific formulation needs?
A: Yes, we can adjust the C8/C10 ratio within a 40-70% range to match specific formulation requirements.
Q: What is the minimum order quantity for export-grade medium chain triglycerides?
A: The minimum order quantity for export orders is 25kg, with sample sizes available for testing purposes.
Contact Us
Official Website: https://byshanhanfang.com/
Factory Address: No.8 Wenquan Avenue, Wenquan Town, Conghua District, Guangzhou, Guangdong Province, China.
